cefiderocol and Neoplasms

cefiderocol has been researched along with Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for cefiderocol and Neoplasms

Article	Year
Activity of Cefiderocol and Comparators against Isolates from Cancer Patients. Antimicrobial agents and chemotherapy, 2020, 04-21, Volume: 64, Issue:5 Cefiderocol inhibited 97.5% of 478 Gram-negative isolates from cancer patients at ≤4 mg/liter. It had potent activity against extended-spectrum β-lactamase-positive Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenem-Resistant Enterobacteriaceae; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Neoplasms; Pseudomonas aeruginosa; Stenotrophomonas maltophilia	2020

Article

Year

Activity of Cefiderocol and Comparators against Isolates from Cancer Patients.

Antimicrobial agents and chemotherapy, 2020, 04-21, Volume: 64, Issue:5

Cefiderocol inhibited 97.5% of 478 Gram-negative isolates from cancer patients at ≤4 mg/liter. It had potent activity against extended-spectrum β-lactamase-positive

Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenem-Resistant Enterobacteriaceae; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Neoplasms; Pseudomonas aeruginosa; Stenotrophomonas maltophilia

2020